357 related articles for article (PubMed ID: 36110860)
1. The key player in the pathogenesis of environmental influence of systemic lupus erythematosus: Aryl hydrocarbon receptor.
Wu J; Pang T; Lin Z; Zhao M; Jin H
Front Immunol; 2022; 13():965941. PubMed ID: 36110860
[TBL] [Abstract][Full Text] [Related]
2. Immunoregulatory effects of indole-3-carbinol on monocyte-derived macrophages in systemic lupus erythematosus: A crucial role for aryl hydrocarbon receptor.
Mohammadi S; Memarian A; Sedighi S; Behnampour N; Yazdani Y
Autoimmunity; 2018 Aug; 51(5):199-209. PubMed ID: 30289282
[TBL] [Abstract][Full Text] [Related]
3. Ultraviolet B inhibition of DNMT1 activity via AhR activation dependent SIRT1 suppression in CD4+ T cells from systemic lupus erythematosus patients.
Wu Z; Mei X; Ying Z; Sun Y; Song J; Shi W
J Dermatol Sci; 2017 Jun; 86(3):230-237. PubMed ID: 28336124
[TBL] [Abstract][Full Text] [Related]
4. AhR-ROR-γt complex is a therapeutic target for MAP4K3/GLK
Chuang HC; Chen YM; Chen MH; Hung WT; Yang HY; Tseng YH; Tan TH
FASEB J; 2019 Oct; 33(10):11469-11480. PubMed ID: 31318609
[TBL] [Abstract][Full Text] [Related]
5. The role of the aryl hydrocarbon receptor (AhR) in modulating intestinal ILC3s to optimise gut pathogen resistance in lupus and benefits of nutritional AhR ligands.
Hanlon N; Gillan N; Neil J; Seidler K
Clin Nutr; 2024 Jun; 43(6):1199-1215. PubMed ID: 38631087
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of aryl hydrocarbon receptor in autoimmunity.
Wang XS; Cao F; Zhang Y; Pan HF
Inflammopharmacology; 2020 Feb; 28(1):63-81. PubMed ID: 31617124
[TBL] [Abstract][Full Text] [Related]
7. PD-1 immunobiology in systemic lupus erythematosus.
Curran CS; Gupta S; Sanz I; Sharon E
J Autoimmun; 2019 Feb; 97():1-9. PubMed ID: 30396745
[TBL] [Abstract][Full Text] [Related]
8. Association between the ratio of aryl hydrocarbon receptor (AhR) in Th17 cells to AhR in Treg cells and SLE skin lesions.
Yu H; Jiang L; Liu R; Yang A; Yang X; Wang L; Zhang W; Che T
Int Immunopharmacol; 2019 Apr; 69():257-262. PubMed ID: 30743201
[TBL] [Abstract][Full Text] [Related]
9. The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis.
Huang W; Rui K; Wang X; Peng N; Zhou W; Shi X; Lu L; Hu D; Tian J
J Autoimmun; 2023 Jul; 138():103049. PubMed ID: 37229809
[TBL] [Abstract][Full Text] [Related]
10. The AHR Signaling Attenuates Autoimmune Responses During the Development of Type 1 Diabetes.
Yue T; Sun F; Yang C; Wang F; Luo J; Yang P; Xiong F; Zhang S; Yu Q; Wang CY
Front Immunol; 2020; 11():1510. PubMed ID: 32849515
[TBL] [Abstract][Full Text] [Related]
11. Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis.
Vuerich M; Harshe R; Frank LA; Mukherjee S; Gromova B; Csizmadia E; Nasser IAM; Ma Y; Bonder A; Patwardhan V; Robson SC; Longhi MS
J Hepatol; 2021 Jan; 74(1):48-57. PubMed ID: 32663496
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in CYP1A1 and AHRR genes increase the risk of systemic lupus erythematosus and exacerbate disease severity in smoker patients.
Saghaeian Jazi M; Mohammadi S; Zare Ebrahimabad M; Sedighi S; Abdolahi N; Tabarraei A; Yazdani Y
J Biochem Mol Toxicol; 2021 Dec; 35(12):e22916. PubMed ID: 34580959
[TBL] [Abstract][Full Text] [Related]
13. Aryl Hydrocarbon Receptor: Its Regulation and Roles in Transformation and Tumorigenesis.
Che X; Dai W
Curr Drug Targets; 2019; 20(6):625-634. PubMed ID: 30411679
[TBL] [Abstract][Full Text] [Related]
14. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology.
Esser C; Rannug A
Pharmacol Rev; 2015; 67(2):259-79. PubMed ID: 25657351
[TBL] [Abstract][Full Text] [Related]
15. Species-Specific Differences in Aryl Hydrocarbon Receptor Responses: How and Why?
Xu X; Zhang X; Yuan Y; Zhao Y; Fares HM; Yang M; Wen Q; Taha R; Sun L
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948089
[TBL] [Abstract][Full Text] [Related]
16. Ligands and agonists of the aryl hydrocarbon receptor AhR: Facts and myths.
Sládeková L; Mani S; Dvořák Z
Biochem Pharmacol; 2023 Jul; 213():115626. PubMed ID: 37247746
[TBL] [Abstract][Full Text] [Related]
17. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.
Forrester AR; Elias MS; Woodward EL; Graham M; Williams FM; Reynolds NJ
J Dermatol Sci; 2014 Jan; 73(1):10-22. PubMed ID: 24161567
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet light converts propranolol, a nonselective β-blocker and potential lupus-inducing drug, into a proinflammatory AhR ligand.
Dorgham K; Amoura Z; Parizot C; Arnaud L; Frances C; Pionneau C; Devilliers H; Pinto S; Zoorob R; Miyara M; Larsen M; Yssel H; Gorochov G; Mathian A
Eur J Immunol; 2015 Nov; 45(11):3174-87. PubMed ID: 26354876
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide-Enhanced Responses against Aryl Hydrocarbon Receptor in FcgRIIb-Deficient Macrophages, a Profound Impact of an Environmental Toxin on a Lupus-Like Mouse Model.
Udompornpitak K; Bhunyakarnjanarat T; Charoensappakit A; Dang CP; Saisorn W; Leelahavanichkul A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919603
[TBL] [Abstract][Full Text] [Related]
20. Aryl Hydrocarbon Receptor Activation Synergistically Induces Lipopolysaccharide-Mediated Expression of Proinflammatory Chemokine (c-c motif) Ligand 20.
Lahoti TS; Boyer JA; Kusnadi A; Muku GE; Murray IA; Perdew GH
Toxicol Sci; 2015 Nov; 148(1):229-40. PubMed ID: 26259605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
